Orion Corporation News - 1ORNBV

Orion Corporation: Managers’ transactions – Hao Pan

Orion Corporation: Managers’ transactions – Hao Pan ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion...

Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024

Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024 ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN...

Orion Group Financial Statement documents 2023, Corporate Governance Statement and Remuneration Report published

Orion Group Financial Statement documents 2023, Corporate Governance Statement and Remuneration Report published ORION CORPORATION STOCK...

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally ORION CORPORATION PRESS...

Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland

Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland ORION CORPORATION PRESS RELEASE 19 FEBRUARY...

Notice to the Annual General Meeting of Orion Corporation

Notice to the Annual General Meeting of Orion Corporation ORION CORPORATION STOCK EXCHANGE RELEASE / NOTICE TO GENERAL MEETING 13 FEBRUARY...

Orion Group Financial Statement Release January–December 2023

Orion Group Financial Statement Release January–December 2023 ORION CORPORATION FINANCIAL STATEMENT RELEASE 1-12/2023 13 FEBRUARY...

119,021 Orion Corporation A shares converted into B shares

119,021 Orion Corporation A shares converted into B shares ORION CORPORATION STOCK EXCHANGE RELEASE - OTHER INFORMATION DISCLOSED ACCORDING...

Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024

Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024 ORION CORPORATION PRESS RELEASE 29 January 2024...

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain ORION...

Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023

Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Orion Corporation (1ORNBV)

Empower your portfolio: Real-time discussions and actionable trading ideas.

1ORNBV News

Orion Corporation: Managers’ transactions – Hao Pan

Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024

Orion Group Financial Statement documents 2023, Corporate Governance Statement and Remuneration Report published

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally

Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland

Notice to the Annual General Meeting of Orion Corporation

Orion Group Financial Statement Release January–December 2023

119,021 Orion Corporation A shares converted into B shares

Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024

Change in Orion Group Executive Management Board – René Lindell appointed Chief Financial Officer of Orion

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General Meeting

Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023

1ORNBV Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Orion Corporation (1ORNBV) News

Orion Corporation (1ORNBV)

Empower your portfolio: Real-time discussions and actionable trading ideas.

1ORNBV News

Orion Corporation: Managers’ transactions – Hao Pan

Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024

Orion Group Financial Statement documents 2023, Corporate Governance Statement and Remuneration Report published

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally

Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland

Notice to the Annual General Meeting of Orion Corporation

Orion Group Financial Statement Release January–December 2023

119,021 Orion Corporation A shares converted into B shares

Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024

Change in Orion Group Executive Management Board – René Lindell appointed Chief Financial Officer of Orion

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General Meeting

Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023

1ORNBV Discussion

Your Recent History